Jeil Pharmaceutical

NCT01693445

S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer

NCT01983358

The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers

NCT02180997

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

NCT02186483

Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin

NCT02387619

The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

NCT02396069

The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers

NCT02447367

Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers

NCT02494349

The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.

NCT03461081

Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

NCT03247140

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

NCT02982798

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

NCT03362008

Compare the Pharmacokinetic Characteristics and the Safety Between Zeropix and Champix in Healthy Adult Male Subjects.

NCT02449187

Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers

NCT04335604

A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors

NCT03383042

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects

NCT03690778

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

NCT03707899

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

NCT05172622

Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects

NCT04914221

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

NCT06171880

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901

NCT06165965

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008

NCT06169059

To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004

NCT06431399

To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004